We and others have reported that GSK3β inhibition attenuates the proliferation, migration and invasion of GBM cells by modulating distinct molecular pathways, and sensitizes them to chemotherapeutic agents and radiation [12–19]. The gene discussed is GSK3B; the disease is glioblastoma.